4.6 Article

Umbilical cord mesenchymal stromal cells as critical COVID-19 adjuvant therapy: A randomized controlled trial

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pathology

Immunopathology of Hyperinflammation in COVID-19

Joshua N. Gustine et al.

Summary: The rapid spread of COVID-19 has led to an unprecedented global public health crisis with recent studies suggesting that the hyperinflammatory syndrome induced by SARS-CoV-2 is a contributing factor to disease severity and mortality. Pathophysiological research shows that the hyperinflammatory syndrome in severe COVID-19 results from a dysregulated innate immune response. Current potential therapeutic approaches are being investigated to modulate the immune response and mitigate lung injury in severe COVID-19.

AMERICAN JOURNAL OF PATHOLOGY (2021)

Review Cardiac & Cardiovascular Systems

Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System

Jacob Roberts et al.

Summary: Meta-analyses have shown individuals with diabetes are at higher risk of severe COVID-19 and have higher mortality rates, likely due to dysregulated immune and inflammatory responses. The role of ACE2 expression dynamics in diabetes on COVID-19 severity is still under investigation.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Article Cell & Tissue Engineering

Umbilical cord mesenchymal stromal cells as critical COVID-19 adjuvant therapy: A randomized controlled trial

Ismail Hadisoebroto Dilogo et al.

Summary: The use of umbilical cord mesenchymal stromal cells (UC-MSCs) as adjuvant treatment for critically ill patients with COVID-19 significantly increases the survival rate by modulating the immune system towards an anti-inflammatory state.

STEM CELLS TRANSLATIONAL MEDICINE (2021)

Review Cell & Tissue Engineering

Stem Cells Therapy as a Possible Therapeutic Option in Treating COVID-19 Patients

Diana Esquivel et al.

Summary: The emergence of the SARS-CoV-2 virus causing COVID-19 has led to a global pandemic with symptoms mainly affecting the respiratory system and involving an immune response. Clinical reports show common symptoms such as fever, dry cough, and shortness of breath. Studies indicate that Mesenchymal stem cell (MSC) therapy may provide relief to COVID-19 patients by modulating immune responses and improving lung functions.

STEM CELL REVIEWS AND REPORTS (2021)

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Article Critical Care Medicine

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Zhe Xu et al.

LANCET RESPIRATORY MEDICINE (2020)

Article Cell & Tissue Engineering

Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19

Vikram Sengupta et al.

STEM CELLS AND DEVELOPMENT (2020)

Review Biochemistry & Molecular Biology

SARS-CoV-2 infection: The role of cytokines in COVID-19 disease

Victor J. Costela-Ruiz et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2020)

Article Engineering, Biomedical

Treatment of Cytokine Storm in COVID-19 Patients With Immunomodulatory Therapy

Lenar Yessayan et al.

ASAIO JOURNAL (2020)

Review Peripheral Vascular Disease

Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses

Eleni Gavriilaki et al.

CURRENT HYPERTENSION REPORTS (2020)

Article Infectious Diseases

CXCR3 chemokine receptor contributes to specific CD8+ T cell activation by pDC during infection with intracellular pathogens

Pontes Camila Ferreira et al.

PLOS NEGLECTED TROPICAL DISEASES (2020)

Article Endocrinology & Metabolism

Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis

Bianca de Almeida-Pititto et al.

DIABETOLOGY & METABOLIC SYNDROME (2020)

Article Cell & Tissue Engineering

Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells

Lei Shu et al.

STEM CELL RESEARCH & THERAPY (2020)

Review Cell & Tissue Engineering

The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm

Maria Kavianpour et al.

STEM CELL RESEARCH & THERAPY (2020)

Review Cell & Tissue Engineering

Insights into the use of mesenchymal stem cells in COVID-19 mediated acute respiratory failure

Nisha Durand et al.

NPJ REGENERATIVE MEDICINE (2020)

Article Immunology

Reduced CD4+T Cell CXCR3 Expression in Patients With Allergic Rhinitis

Xiaofeng Yu et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Endocrinology & Metabolism

Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis

Ashish Kumar et al.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)

Article Biochemistry & Molecular Biology

Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial

Fanping Meng et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Review Immunology

Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs

Andreas Robert Rudolf Weiss et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Immunology

IL-10: A Multifunctional Cytokine in Viral Infections

Jose M. Rojas et al.

JOURNAL OF IMMUNOLOGY RESEARCH (2017)

Review Immunology

Regulation of adaptive immunity; the role of interleukin-10

T. H. Sky Ng et al.

FRONTIERS IN IMMUNOLOGY (2013)